<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04238442</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00079695</org_study_id>
    <nct_id>NCT04238442</nct_id>
  </id_info>
  <brief_title>Assessing the Accuracy of the A&amp;D TM-2657W Oscillometric Device</brief_title>
  <official_title>Assessing the Accuracy of the A&amp;D TM-2657W Oscillometric Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>A&amp;D Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The A&amp;D automatic blood pressure device is a new kiosk that can measure blood pressure in the
      general population.

      The investigators plan to use the existing International Standards Organization validation
      protocol to determine whether this device measures blood pressure accurately.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods and Analysis

      Study methodology will follow the ISO protocol:

        -  85 adult (age 18 years or greater) subjects will be included (it is estimated that
           approximately 140 subjects will need to be screened as some will be ineligible). 85 is
           the recommended sample size for validation studies using the ISO protocol.

        -  Subjects will be recruited via an existing registry of over 250 individuals that have
           participated in past measurement studies, through advertisements, and from the
           University of Alberta Hypertension Clinic.

        -  Specific requirements for a certain percentage of subjects with specific age, sex, upper
           arm circumference, and baseline blood pressure levels will be observed to ensure that a
           representative sample is studied (according to the ISO standards).

        -  Subjects that are pregnant or with atrial fibrillation will be excluded. Blood pressure
           measurements will be taken using recommended, optimal technique.

        -  Nine measurements will be taken in each subject, alternating between blinded
           two-observer auscultation with a mercury-based sphygmomanometer (the reference standard)
           and the TM-2657. Careful attention will be paid to ensuring proper cuffing. The first
           two measurements will be discarded and the latter seven measurements (4 auscultatory and
           TM-2657 measurements) will be used in the analysis, which will be conducted according to
           ISO standards.

        -  Accuracy will be assessed according to Criterion 1 and 2 of the ISO standard.
           Bland-Altman plots will be generated. A plot of measurement error versus arm
           circumference will be generated as well.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 14, 2019</start_date>
  <completion_date type="Actual">February 5, 2020</completion_date>
  <primary_completion_date type="Actual">February 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy per International Standards Organization Protocol</measure>
    <time_frame>3 months</time_frame>
    <description>Agreement of the device to mercury auscultation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>BP oscillometric measurement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oscillometric BP measurement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A&amp;D TM-2657W oscillometric device</intervention_name>
    <description>Assessing the accuracy of the A&amp;D TM-2657W oscillometric device using International Standards Organization validation protocol. This involves comparing the accuracy of the A&amp;D device to 2 observer mercury auscultation (gold standard).</description>
    <arm_group_label>BP oscillometric measurement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  normal sinus rhythm

          -  have capacity to give consent

          -  following the International Standards Organization criteria for: gender distribution,
             limb size, blood pressure distribution

        Exclusion Criteria:

          -  atrial fibrillation

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Ringrose, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 1, 2019</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2020</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

